Corrigendum: Dendritic cell proliferation by primary cilium in atopic dermatitis

• Manami Toriyama,
• Manami Toriyama,
• Manami Toriyama,
• Defri Rizaldy,
• Defri Rizaldy,
• Defri Rizaldy,
• Motoki Nakamura,
• Motoki Nakamura,
• Yukiko Atsumi,
• Yukiko Atsumi,
• Michinori Toriyama,
• Fumitaka Fujita,
• Fumitaka Fujita,
• Fumitaka Fujita,
• Fumihiro Okada,
• Fumihiro Okada,
• Akimichi Morita,
• Hiroshi Itoh,
• Ken J. Ishii,
• Ken J. Ishii

Affiliations

Manami Toriyama

Graduate School of Pharmacological Sciences, Osaka University, Osaka, Japan

Manami Toriyama

Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan

Manami Toriyama

Graduate School of Science and Technology, Nara Institute of Science and Technology, Nara, Japan

Defri Rizaldy

Graduate School of Pharmacological Sciences, Osaka University, Osaka, Japan

Defri Rizaldy

Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan

Defri Rizaldy

School of Pharmacy, Institut Teknologi Bandung, Bandung, Indonesia

Motoki Nakamura

Graduate School of Pharmacological Sciences, Osaka University, Osaka, Japan

Motoki Nakamura

Department of Geriatric and Environmental Dermatology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

Yukiko Atsumi

Graduate School of Pharmacological Sciences, Osaka University, Osaka, Japan

Yukiko Atsumi

Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan

Michinori Toriyama

School of Biological and Environmental Sciences, Kwansei Gakuin University, Hyogo, Japan

Fumitaka Fujita

Graduate School of Pharmacological Sciences, Osaka University, Osaka, Japan

Fumitaka Fujita

Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan

Fumitaka Fujita

Mandom Corporation, Osaka, Japan

Fumihiro Okada

Graduate School of Pharmacological Sciences, Osaka University, Osaka, Japan

Fumihiro Okada

Mandom Corporation, Osaka, Japan

Akimichi Morita

Department of Geriatric and Environmental Dermatology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

Hiroshi Itoh

Graduate School of Science and Technology, Nara Institute of Science and Technology, Nara, Japan

Ken J. Ishii

Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan

Ken J. Ishii

Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan